-
BOP Reagent: Coupling Chemistry for Prodrug Design
2026-08-28
BOP reagent, also called benzotriazol-1-yloxy-tris(dimethylamino)phosphanium hexafluorophosphate, activates carboxyl groups for synthetic amide bond formation and phenyl ester preparation. Product specifications support dry, cold storage and prompt use of freshly prepared organic-solvent solutions, while the cited OSCC study provides biological context rather than direct evidence of BOP-mediated drug efficacy.
-
Parthenolide, ROS, and Lymphoid Cancer Apoptosis
2026-08-28
Jorge and colleagues show that parthenolide reduces metabolic activity and promotes oxidative-stress-associated apoptosis across diverse B- and T-lineage lymphoid malignancy models. By integrating a resazurin-based cell viability assay with flow cytometry and gene-expression analyses, the study connects redox imbalance, mitochondrial dysfunction, and cell-line-dependent responses to NF-κB inhibition.
-
Resazurin Cell Viability Assay Kit in ROS Studies
2026-08-27
The Resazurin Cell Viability Assay Kit provides a sensitive redox-based readout for cell viability and proliferation. This guide explains how to interpret resazurin signals in ROS-driven apoptosis studies, using lymphoid malignancy research to define sound assay design and validation strategies.
-
Cefepime (BMY-28142) in Reliable Cell Assays
2026-08-27
Learn how to use Cefepime (BMY-28142), SKU BA1013, without confusing antimicrobial effects with mammalian cell viability or cytotoxicity. This scenario-based guide connects storage, assay controls, resistance modeling, neurotoxicity studies, and practical product-selection criteria.
-
ICG001 in Biliary Atresia Fibrosis Research
2026-08-26
Explore how ICG001, a selective Wnt/β-catenin pathway inhibitor, can clarify whether MMP7-driven fibrosis depends on CBP-mediated transcription. This article translates recent biliary atresia findings into a disciplined assay strategy that separates β-catenin localization, adhesion loss, and transcriptional output.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-08-26
Build sensitive, reproducible immunofluorescence, IHC, ICC, and flow cytometry workflows around a Cy3-conjugated secondary antibody for rabbit primary antibodies. The approach translates rheumatoid arthritis mechanism research into practical controls, imaging decisions, and troubleshooting steps without overstating product-specific validation.
-
DMG-PEG2000-NH2 for LNP Workflows
2026-08-25
DMG-PEG2000-NH2 combines a lipid-compatible PEG spacer with a reactive primary amine for modular bioconjugation. This article translates its chemistry into practical liposome, lipid nanoparticle, and siRNA assay workflows while using antimycobacterial SAR research to strengthen payload and safety controls.
-
Erastin and the Translational Logic of Ferroptosis
2026-08-25
Erastin is more than a cytotoxicity reagent: it is a mechanistic probe for redox vulnerability, oncogenic context, and tumor metabolism. This article connects ferroptosis research with translational assay design, the RAS-RAF-MEK signaling pathway, and emerging metabolic nanoregulation strategies while defining practical limits for interpretation.
-
Azathramycin A: A Translational TB Strategy
2026-08-24
Azathramycin A offers a research lens on ribosome-directed antibacterial activity, degradation-aware assay design, and site-of-action pharmacology. This thought-leadership guide translates macrolide exposure–response principles into a disciplined framework for Mycobacterium tuberculosis studies without overstating evidence from other disease models.
-
Epoxomicin: A Proteasome Probe for Viral Inflammation
2026-08-24
Epoxomicin is an irreversible proteasome inhibitor that can do more than block protein turnover: it helps distinguish viral control of RIPK3 degradation from downstream proteolytic execution. This article translates a pivotal orthopoxvirus study into practical assay logic for ubiquitin-proteasome pathway research.
-
TH287 Radiosensitizes CRPC Cells to Ionizing Radiation
2026-08-23
A 2026 study found that TH287, an MTH1 inhibitor, enhanced ionizing-radiation responses in PC-3 and DU-145 castration-resistant prostate cancer cells. The strongest effect occurred when radiation was delivered 12 hours after TH287 exposure, with increased apoptosis, caspase-3 changes, and cell-cycle arrest supporting a timing-sensitive radiosensitization strategy.
-
Calpain Inhibitor I, ALLN: Workflow Guide
2026-08-22
Calpain Inhibitor I, ALLN (SKU A2602) provides a practical way to inhibit calpain I, calpain II, and selected cathepsins in controlled apoptosis, inflammation, and ischemia-reperfusion studies. It is intended for research workflows only; concentrations, exposure conditions, and in vivo dosing must be established for each model rather than inferred from biochemical potency values.
-
Lipo3K Transfection Reagent for Smart ASO Assays
2026-08-22
Explore how Lipo3K Transfection Reagent can support rigorous nucleic acid assay design, from difficult cell models to pH-responsive antisense oligonucleotide studies. This guide connects delivery performance with cargo structure, controls, timing, and interpretation.
-
HBsAg Hijacks TBK1 to Suppress Interferon
2026-08-21
A 2025 Cell Death and Disease study identifies TBK1 as a central host target through which hepatitis B surface antigen suppresses type I interferon signaling while promoting incomplete autophagy. The work connects HBsAg-dependent TBK1 dimerization, disrupted TBK1–IRF3 signaling, p62 phosphorylation, and impaired autophagosome–lysosome fusion to HBV replication and possible viral persistence.
-
Deferoxamine Mesylate: Iron-Chelation Research Guide
2026-08-20
Deferoxamine mesylate is an iron-chelating agent that forms ferrioxamine and reduces the pool of chemically available iron. Research evidence supports its use in iron metabolism, oxidative stress protection, HIF-1α stabilization, and model-specific tissue or tumor studies, while the TCF25 study provides a separate framework for interpreting iron-linked lysosomal stress.